876
Views
73
CrossRef citations to date
0
Altmetric
Reviews

The potential of adeno-associated viral vectors for gene delivery to muscle tissue

, , & , PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Seyed Zachariah Moradi, Faramarz Jalili, Negin Farhadian, Tanuj Joshi, Mingfu Wang, Liang Zou, Hui Cao, Mohammad Hosein Farzaei & Jianbo Xiao. (2022) Polyphenols and neurodegenerative diseases: focus on neuronal regeneration. Critical Reviews in Food Science and Nutrition 62:13, pages 3421-3436.
Read now
Sara Aguti, Alberto Malerba & Haiyan Zhou. (2018) The progress of AAV-mediated gene therapy in neuromuscular disorders. Expert Opinion on Biological Therapy 18:6, pages 681-693.
Read now
Mohammad Alsaggar & Dexi Liu. (2018) Organ-based drug delivery. Journal of Drug Targeting 26:5-6, pages 385-397.
Read now
Eric Hastie & R Jude Samulski. (2015) Recombinant adeno-associated virus vectors in the treatment of rare diseases. Expert Opinion on Orphan Drugs 3:6, pages 675-689.
Read now

Articles from other publishers (68)

Zongrui Shen, Meiyi Li, Fei He, Cheng Huang, Yingchun Zheng, Zhikui Wang, Shunfei Ma, Li Chen, Zhengshan Liu, Hui Zheng & Fu Xiong. (2023) Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-/- Mice. Neurotherapeutics 20:6, pages 1835-1846.
Crossref
Tatiana V. Egorova, Anna V. Polikarpova, Svetlana G. Vassilieva, Marina A. Dzhenkova, Irina M. Savchenko, Oleg A. Velyaev, Anna A. Shmidt, Vladislav O. Soldatov, Mikhail V. Pokrovskii, Alexey V. Deykin & Maryana V. Bardina. (2023) CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein. Molecular Therapy - Methods & Clinical Development 30, pages 161-180.
Crossref
Juliana Popovitz, Rohit Sharma, Reyhane Hoshyar, Beob Soo Kim, Niren Murthy & Kunwoo Lee. (2023) Gene editing therapeutics based on mRNA delivery. Advanced Drug Delivery Reviews 200, pages 115026.
Crossref
Addeli Bez Batti Angulski, Nora Hosny, Houda Cohen, Ashley A. Martin, Dongwoo Hahn, Jack Bauer & Joseph M. Metzger. (2023) Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Frontiers in Physiology 14.
Crossref
Yuqing Wang, Ayrea Hurley, Marco De Giorgi, Mark R. Tanner, Rong-Chi Hu, Michael W. Pennington, William R. Lagor & Christine Beeton. (2023) Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver. PLOS ONE 18:4, pages e0283996.
Crossref
Carola J. Maturana, Angela Chan, Jessica L. Verpeut & Esteban A. Engel. (2023) Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle. Journal of Virological Methods 314, pages 114688.
Crossref
Hossein Hosseinkhani, Abraham J. Domb, Ghorbanali Sharifzadeh & Victoria Nahum. (2023) Gene Therapy for Regenerative Medicine. Pharmaceutics 15:3, pages 856.
Crossref
Darya A. Savenkova, Aelita-Luiza A. Makarova, Igor K. Shalik & Dmitry V. Yudkin. (2022) miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy. International Journal of Molecular Sciences 23:23, pages 14954.
Crossref
Audrey Bourdon, Virginie François, Liwen Zhang, Aude Lafoux, Bodvael Fraysse, Gilles Toumaniantz, Thibaut Larcher, Tiphaine Girard, Mireille Ledevin, Cyrielle Lebreton, Agnès Hivonnait, Anna Creismeas, Marine Allais, Basile Marie, Justine Guguin, Véronique Blouin, Séverine Remy, Ignacio Anegon, Corinne Huchet, Alberto Malerba, Betty Kao, Anita Le Heron, Philippe Moullier, George Dickson, Linda Popplewell, Oumeya Adjali, Federica Montanaro & Caroline Le Guiner. (2022) Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model. Gene Therapy 29:9, pages 520-535.
Crossref
Lisbeth Liliendal Valbjørn Møller, Steffen Henning Raun, Andreas Mæchel Fritzen & Lykke Sylow. (2022) Measurement of skeletal muscle glucose uptake in mice in response to acute treadmill running. Journal of Biological Methods 9:3, pages e162.
Crossref
Karen K. McKee & Peter D. Yurchenco. (2022) Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-αLN linker protein. JCI Insight 7:13.
Crossref
A. A. Soldatov, Zh. I. Avdeeva, D. V. Gorenkov, L. M. Khantimirova, S. G. Guseva & V. A. Merkulov. (2022) Challenges in development and authorisation of gene therapy products. Biological Products. Prevention, Diagnosis, Treatment 22:1, pages 6-22.
Crossref
Ryohei Oya, Osamu Tsukamoto, Tatsuro Hitsumoto, Naoya Nakahara, Chisato Okamoto, Ken Matsuoka, Hisakazu Kato, Hidenori Inohara & Seiji Takashima. (2022) Gene Transfer of Skeletal Muscle-Type Myosin Light Chain Kinase via Adeno-Associated Virus 6 Improves Muscle Functions in an Amyotrophic Lateral Sclerosis Mouse Model. International Journal of Molecular Sciences 23:3, pages 1747.
Crossref
Della Grace Thomas Parambi, Khalid Saad Alharbi, Rajesh Kumar, Seetha Harilal, Gaber El-Saber Batiha, Natália Cruz-Martins, Omnia Magdy, Arafa Musa, Dibya Sundar Panda & Bijo Mathew. (2021) Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. Molecular Neurobiology 59:1, pages 191-233.
Crossref
Jinyu Kang, Lujie Hang, Wentao Zheng, Jia Luo, Xie Zhang, Yufei Song & Aiming Liu. (2021) Promoter CAG is more efficient than hepatocyte‑targeting TBG for transgene expression via rAAV8 in liver tissues. Molecular Medicine Reports 25:1.
Crossref
Shubham Musale & Prabhanjan Giram. (2021) NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER. Indian Drugs 58:05, pages 7-20.
Crossref
Arvind Srivastava, Krishna M.G. Mallela, Nandkumar Deorkar & Ger Brophy. (2021) Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors. Journal of Pharmaceutical Sciences 110:7, pages 2609-2624.
Crossref
Anthony A. Stephenson & Kevin M. Flanigan. 2021. Curing Genetic Diseases Through Genome Reprogramming. Curing Genetic Diseases Through Genome Reprogramming 225 255 .
Richard E. Decker, Zachary E. Lamantia, Todd S. Emrick & Marxa L. Figueiredo. (2020) Sonodelivery in Skeletal Muscle: Current Approaches and Future Potential. Bioengineering 7:3, pages 107.
Crossref
Michael Davitt, Shamik Mascharak, Heather desJardins-Park, Malini Chinta, Derrick C. Wan & Michael T. Longaker. (2020) Rewriting the Future: Promises and Limits of Germline Gene Editing in Craniofacial Surgery. Journal of Craniofacial Surgery 31:6, pages 1517-1520.
Crossref
Monika Kustermann, Matthew J. Rok, Ronald D. Cohn & Evgueni A. Ivakine. (2020) In Vivo Genome Engineering for the Treatment of Muscular Dystrophies. Current Stem Cell Reports 6:3, pages 52-66.
Crossref
Joanne Marie M. Del Rosario, Matthew Smith, Kam Zaki, Paul Risley, Nigel Temperton, Othmar G. Engelhardt, Mary Collins, Yasuhiro Takeuchi & Simon E. Hufton. (2020) Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity. Frontiers in Immunology 11.
Crossref
Lili A. Gundelach, Marc A. Hüser, Dirk Beutner, Patrick Ruther & Tobias Bruegmann. (2020) Towards the clinical translation of optogenetic skeletal muscle stimulation. Pflügers Archiv - European Journal of Physiology 472:5, pages 527-545.
Crossref
José M. Martinez-Navio, Sebastian P. Fuchs, Desiree E. Mendes, Eva G. Rakasz, Guangping Gao, Jeffrey D. Lifson & Ronald C. Desrosiers. (2020) Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV. Frontiers in Immunology 11.
Crossref
Sandra Lopez-Leon, Yeimy González-Giraldo, Leon Ruiter-Lopez & Talia Wegman-Ostrosky. 2020. Genome Plasticity in Health and Disease. Genome Plasticity in Health and Disease 237 262 .
Angela L. McCall, Sylvia G. Stankov, Gabrielle Cowen, Denise Cloutier, Zizhao Zhang, Lin Yang, Nathalie Clement, Darin J. Falk & Barry J. Byrne. (2019) Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy. Current Gene Therapy 19:3, pages 197-207.
Crossref
Taro TomonoYukihiko HiraiHideto ChonoJunichi MinenoAkiko IshiiMasafumi OnoderaAkira TamaokaTakashi Okada. (2019) Infectivity Assessment of Recombinant Adeno-Associated Virus and Wild-Type Adeno-Associated Virus Exposed to Various Diluents and Environmental Conditions. Human Gene Therapy Methods 30:4, pages 137-143.
Crossref
Yuanyuan Xiao, Manish Muhuri, Shaoyong Li, Wanru Qin, Guangchao Xu, Li Luo, Jia Li, Alexander J. Letizia, Sean K. Wang, Ying Kai Chan, Chunmei Wang, Sebastian P. Fuchs, Dan Wang, Qin Su, M. Abu Nahid, George M. Church, Michael Farzan, Li Yang, Yuquan Wei, Ronald C. Desrosiers, Christian Mueller, Phillip W.L. Tai & Guangping Gao. (2019) Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity. JCI Insight 4:13.
Crossref
Selene Ingusci, Gianluca Verlengia, Marie Soukupova, Silvia Zucchini & Michele Simonato. (2019) Gene Therapy Tools for Brain Diseases. Frontiers in Pharmacology 10.
Crossref
Derek B.J. Bone, Jaroslawna Meister, Jonas R. Knudsen, Diptadip Dattaroy, Amanda Cohen, Regina Lee, Huiyan Lu, Daniel Metzger, Thomas E. Jensen & Jürgen Wess. (2019) Skeletal Muscle–Specific Activation of Gq Signaling Maintains Glucose Homeostasis. Diabetes 68:6, pages 1341-1352.
Crossref
Slawomir Andrzejewski, Aparna Murali, Charmaine Ramlogan-Steel, Katie P. Edwards, Nathan Efron, Jason C. Steel & Christopher J. Layton. (2019) Adeno-associated virus neutralising antibodies in type 1 diabetes mellitus. Gene Therapy 26:6, pages 250-263.
Crossref
Dan Wang, Phillip W. L. Tai & Guangping Gao. (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nature Reviews Drug Discovery 18:5, pages 358-378.
Crossref
Sandra R. Bacman & Carlos T. Moraes. 2019. Muscle Gene Therapy. Muscle Gene Therapy 597 620 .
Jean-Baptiste Dupont, Michael W. Lawlor & Martin K. Childers. 2019. Muscle Gene Therapy. Muscle Gene Therapy 565 577 .
Dongsheng Duan. 2019. Muscle Gene Therapy. Muscle Gene Therapy 291 326 .
Nathalie Clément. 2019. Muscle Gene Therapy. Muscle Gene Therapy 253 273 .
Michael E. Nance & Dongsheng Duan. 2019. Muscle Gene Therapy. Muscle Gene Therapy 193 206 .
Dongsheng Duan. (2018) Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy. Molecular Therapy 26:10, pages 2337-2356.
Crossref
Peter D. Yurchenco, Karen K. McKee, Judith R. Reinhard & Markus A. Rüegg. (2018) Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix Biology 71-72, pages 174-187.
Crossref
Jérôme Denard, Jérémy Rouillon, Thibaut Leger, Camille Garcia, Michele P. Lambert, Graziella Griffith, Christine Jenny, Jean-Michel Camadro, Luis Garcia & Fedor Svinartchouk. (2018) AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6. Molecular Therapy - Methods & Clinical Development 10, pages 291-302.
Crossref
Rachael A. PotterDanielle A. GriffinPatricia C. SondergaardRyan W. JohnsonEric R. PozsgaiKristin N. HellerEllyn L. PetersonKimmo K. LehtimäkiHillarie P. WindishPlavi J. MittalDouglas E. AlbrechtJerry R. MendellLouise R. Rodino-Klapac. (2018) Systemic Delivery of Dysferlin Overlap Vectors Provides Long-Term Gene Expression and Functional Improvement for Dysferlinopathy. Human Gene Therapy 29:7, pages 749-762.
Crossref
Elizabeth Brandon-WarnerJennifer H. BenbowJacob H. SwetNicole A. FeilenCatherine R. CulbersonIain H. McKillopAndrew S. deLemosMark W. RussoLaura W. Schrum. (2018) Adeno-Associated Virus Serotype 2 Vector–Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis. Human Gene Therapy 29:6, pages 674-686.
Crossref
Hartwig Seitter & Alexandra Koschak. (2018) Relevance of tissue specific subunit expression in channelopathies. Neuropharmacology 132, pages 58-70.
Crossref
Ares Pasipoularides. (2018) Implementing genome-driven personalized cardiology in clinical practice. Journal of Molecular and Cellular Cardiology 115, pages 142-157.
Crossref
Francesca Gatto, Barbara Rossi, Antonietta Tarallo, Elena Polishchuk, Roman Polishchuk, Alessandra Carrella, Edoardo Nusco, Filomena Grazia Alvino, Francesca Iacobellis, Elvira De Leonibus, Alberto Auricchio, Graciana Diez-Roux, Andrea Ballabio & Giancarlo Parenti. (2017) AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease. Scientific Reports 7:1.
Crossref
S E Gombash, C J Cowley, J A Fitzgerald, C A Lepak, M G Neides, K Hook, L J Todd, G-D Wang, C Mueller, B K Kaspar, E C Bielefeld, A J Fischer, J D Wood & K D Foust. (2017) Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques. Gene Therapy 24:10, pages 640-648.
Crossref
Michael F. Naso, Brian Tomkowicz, William L. PerryIIIIII & William R. Strohl. (2017) Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. BioDrugs 31:4, pages 317-334.
Crossref
Maria Sara Cipolat Mis, Simona Brajkovic, Francesco Tafuri, Nereo Bresolin, Giacomo P. Comi & Stefania Corti. (2016) Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders. Molecular Neurobiology 54:6, pages 4466-4476.
Crossref
Caroline Le Guiner, Laurent Servais, Marie Montus, Thibaut Larcher, Bodvaël Fraysse, Sophie Moullec, Marine Allais, Virginie François, Maeva Dutilleul, Alberto Malerba, Taeyoung Koo, Jean-Laurent Thibaut, Béatrice Matot, Marie Devaux, Johanne Le Duff, Jack-Yves Deschamps, Inès Barthelemy, Stéphane Blot, Isabelle Testault, Karim Wahbi, Stéphane Ederhy, Samia Martin, Philippe Veron, Christophe Georger, Takis Athanasopoulos, Carole Masurier, Federico Mingozzi, Pierre Carlier, Bernard Gjata, Jean-Yves Hogrel, Oumeya Adjali, Fulvio Mavilio, Thomas Voit, Philippe Moullier & George Dickson. (2017) Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Nature Communications 8:1.
Crossref
Chaitanya R. Joshi, Vinod Labhasetwar & Anuja Ghorpade. (2017) Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery. Journal of Neuroimmune Pharmacology 12:1, pages 51-83.
Crossref
Daniel R. Miranda, Monica Wong, Shannon H. Romer, Cynthia McKee, Gabriela Garza-Vasquez, Alyssa C. Medina, Volker Bahn, Andrew D. Steele, Robert J. Talmadge & Andrew A. Voss. (2017) Progressive Cl− channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington’s mice. Journal of General Physiology 149:1, pages 55-74.
Crossref
Sebastian P. Fuchs, José M. Martinez-Navio, Guangping Gao & Ronald C. Desrosiers. (2016) Recombinant AAV Vectors for Enhanced Expression of Authentic IgG. PLOS ONE 11:6, pages e0158009.
Crossref
E W I Neuberger, I Perez, C Le Guiner, D Moser, T Ehlert, M Allais, P Moullier, P Simon & R O Snyder. (2016) Establishment of two quantitative nested qPCR assays targeting the human EPO transgene. Gene Therapy 23:4, pages 330-339.
Crossref
Otto-Wilhelm Merten & Bruno Gaillet. (2016) Viral vectors for gene therapy and gene modification approaches. Biochemical Engineering Journal 108, pages 98-115.
Crossref
J Kevin Donahue. (2016) Cardiac gene therapy: a call for basic methods development. The Lancet 387:10024, pages 1137-1139.
Crossref
Y F Wu, W F Mao, Y L Zhou, X T Wang, P Y Liu & J B Tang. (2015) Adeno-associated virus-2-mediated TGF-β1 microRNA transfection inhibits adhesion formation after digital flexor tendon injury. Gene Therapy 23:2, pages 167-175.
Crossref
O. A. Bezborodova, E. R. Nemtsova, R. I. Yakubovskaya & A. D. Kaprin. (2016) Gene therapy is a new area in medicine. Onkologiya. Zhurnal imeni P.A.Gertsena 5:2, pages 64.
Crossref
Maria Schnödt, Marco Schmeer, Barbara Kracher, Christa Krüsemann, Laura Escalona Espinosa, Anja Grünert, Thomas Fuchsluger, Anja Rischmüller, Martin Schleef & Hildegard Büning. (2016) DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations. Molecular Therapy - Nucleic Acids 5, pages e355.
Crossref
Helena Escobar, Verena Schöwel, Simone Spuler, Andreas Marg & Zsuzsanna Izsvák. (2016) Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle. Molecular Therapy - Nucleic Acids 5, pages e277.
Crossref
Sebastian P Fuchs & Ronald C Desrosiers. (2016) Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies. Molecular Therapy - Methods & Clinical Development 3, pages 16068.
Crossref
C. Kibaly, H.H. Loh & P.-Y. Law. 2016. 89 161 .
Dominic J. Gessler & Guangping Gao. 2016. Gene Therapy for Neurological Disorders. Gene Therapy for Neurological Disorders 429 465 .
Simon Fischer, René Handrick & Kerstin Otte. (2015) The art of CHO cell engineering: A comprehensive retrospect and future perspectives. Biotechnology Advances 33:8, pages 1878-1896.
Crossref
Sebastian P. Fuchs, José M. Martinez-Navio, Michael Piatak, Jeffrey D. Lifson, Guangping Gao & Ronald C. Desrosiers. (2015) AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity. PLOS Pathogens 11:8, pages e1005090.
Crossref
E V Gurevich & V V Gurevich. (2015) Beyond traditional pharmacology: new tools and approaches. British Journal of Pharmacology 172:13, pages 3229-3241.
Crossref
Fabian Stiefel, Simon Fischer, Matthias Hackl, René Handrick, Friedemann Hesse, Nicole Borth, Kerstin Otte & Johannes Grillari. (2015) Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells. Pharmaceutical Bioprocessing 3:3, pages 227-247.
Crossref
Chao Liu, Leiying Miao, Weibin Sun, Xiaonan Wu, Fuhua Yan, Hongchen Sun & Changyu Zheng. (2014) Assessment of Transfection of AdCMV-EGFP to Rat Submandibular Gland Cells. Cell Biochemistry and Biophysics 71:1, pages 147-153.
Crossref
Eleni Papanikolaou & Nicholas P. Anagnou. 2015. Introduction to Translational Cardiovascular Research. Introduction to Translational Cardiovascular Research 553 564 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.